The proposal would provide $270,000 over 2 years to progress research into Creutzfeldt–Jakob disease (CJD), with the CJD Support Group Network leading the research.

The funding would be distributed as $175,000 in 2027-28 and $95,000 in 2028-29.

The proposal would be non-ongoing and would start from 1 July 2027.